Sinofn Health
At SINOFN, we redefine the role of an OEM partner by moving beyond simple manufacturing. Our technology roadmap focuses on three pillars: Bioavailability Enhancement, Clean Label Formulation, and Precision Nutrition. By utilizing advanced delivery systems like encapsulated softgels and sustained-release powders, we ensure that your brand delivers efficacy, not just ingredients. Our R&D team continuously maps global consumer health trends against metabolic data to create next-generation formulations that dominate market shelves.
In an era of global volatility, supply chain stability is the ultimate competitive advantage. Our "Factory 4.0" initiative integrates AI-driven inventory management, IoT-enabled production lines, and rigorous blockchain traceability. By digitizing the manufacturing floor, we provide global enterprise clients with real-time transparency—from raw material sourcing to final batch release. We don't just fill orders; we build redundant, secure, and efficient manufacturing pathways that safeguard your brand's continuity.
Navigating the complex landscape of international food and supplement regulation (FDA, EU EFSA, HALAL) requires an expert hand. SINOFN provides comprehensive regulatory documentation support, ensuring your products transition smoothly across borders. We specialize in handling high-volume, diverse SKU requirements for large-scale nutraceutical retailers, offering localized technical support that bridges the gap between Asian manufacturing precision and Western market standards.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
Driven by a mission to bridge the gap in affordable clinical nutrition (PKU), Mrs. Liu founded SINOFN with a "Profit with Purpose" philosophy. Her legacy drives our R&D focus on metabolic health and medical foods.
Led by Dr. Zhang Ying (CAS Postdoc) and Dr. Tan Shengjie (Peking University), our team combines Dutch engineering expertise with Chinese biotechnological innovation, ensuring your products are formulated at the cutting edge of science.
Q: Where are your facilities located?
We operate state-of-the-art facilities in China, optimized for global logistics and high-capacity production.
Q: Can you support R&D and rapid prototyping?
Yes. We offer pilot-scale prototyping for tablets, capsules, and liquids to accelerate your time-to-market.
Q: Do you work with startups and large enterprises?
We provide tailored scopes for both startups needing low MOQ agility and large enterprises requiring massive, consistent supply-chain throughput.